The Economic Times put Dr. Reddy’s Laboratories shares below their 20-day exponential moving average in an early Oct. 22 update, ahead of the company’s planned results announcement after Friday’s board meeting.
The update, timestamped 12:07 a.m. ET (04:07 UTC), listed the share price at ₹1,214.50 and the EMA at ₹1,214.88. It also reported a 2.25% fall at that point.
Later on Oct. 22, The Economic Times’ 8:31 a.m. ET (12:31 UTC) snapshot and Moneycontrol’s Oct. 22 listing both put the shares at ₹1,239. Moneycontrol showed a decline of ₹5.50, or 0.44%.
In a filing with the U.S. Securities and Exchange Commission (SEC), Dr. Reddy’s said its board would consider unaudited standalone and consolidated results for the quarter and six-month period through Sept. 30 on Oct. 23, after which the company planned to announce them. A management earnings call is scheduled for 10 a.m. ET (14:00 UTC) that day.
